Geballe Daniel W 4
4 · LEVI STRAUSS & CO · Filed Feb 27, 2026
Research Summary
AI-generated summary of this filing
Levi Strauss Director Daniel W. Geballe Receives 74-Share Award
What Happened
- Daniel W. Geballe, a director of Levi Strauss & Co. (LEVI), received an award of 74 dividend-equivalent rights (DERs) on Feb 25, 2026. The filing shows 74 shares at $0.00 (grant = $0 cash outlay).
- This was an award (not an open‑market purchase or sale). Each DER is a contingent right to receive one share of Class A common stock upon settlement.
Key Details
- Transaction date: 2026-02-25; Form filed: 2026-02-27 (timely based on the report).
- Reported grant: 74 DERs @ $0.00 (total reported cash value $0).
- Shares owned after transaction: not specified in the provided filing.
- Footnote: The DERs vest 100% on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the grant date; upon settlement each DER converts to one share of Class A common stock.
- Transaction code: A = Award/Grant; no 10b5-1, tax‑withholding, or late‑filing flags noted in the provided data.
Context
- DERs are a form of deferred equity: they don’t immediately deliver stock but entitle the holder to receive shares later (here, once vesting/settlement conditions are met).
- Because this is a routine equity award to an insider (director), it’s a compensation event rather than a direct market purchase or sale; it should be interpreted as part of standard director pay, not necessarily a personal buy/sell signal.
Insider Transaction Report
Form 4
Geballe Daniel W
Director
Transactions
- Award
Class A Common Stock
[F1]2026-02-25+74→ 11,791 total
Footnotes (1)
- [F1]Represents dividend equivalent rights (DERs), each of which represents a contingent right to receive one share of the issuer's Class A Common Stock upon settlement. The DERs shall vest as to 100% of the shares on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the date of grant of the underlying award.
Signature
/s/ Priscilla Duncan-Tannous, Attorney-in-Fact|2026-02-27